AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-88243314/novirio-becomes-idenix-pharmaceuticals.html" title="Facts and information about Novirio becomes Idenix Pharmaceuticals, Inc.(Brief Article)">Novirio becomes Idenix Pharmaceuticals, Inc.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Virus Weekly are available.
Frequently asked questions about RSS feeds
Novirio becomes Idenix Pharmaceuticals, Inc.(Brief Article)
2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Novirio Pharmaceuticals, Ltd., has changed its name to Idenix Pharmaceuticals, Inc.
The new name, Idenix, is intended to reflect the application of its drug discovery expertise and development experience in the areas of hepatitis B, hepatitis C and HIV and the potential application of this expertise and experience to the treatment of other infectious diseases.
Idenix is a ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Novirio Pharmaceuticals Limited Becomes Idenix Pharmaceuticals, Inc.
- Press release article from: PR Newswire May 29, 2002 700+ words
...and other infectious diseases, today announced...its name to Idenix Pharmaceuticals, Inc. The...of other infectious diseases. About Idenix: Idenix Pharmaceuticals, Inc...and other infectious diseases. Idenix...
- Idenix to present positive results on telbivudine.(American Association for the...
- Newspaper article from: Pharma Marketletter October 10, 2005 700+ words
US infectious diseases specialist Idenix Pharmaceuticals says that five abstracts concerning its products have been accepted for presentation at the 56th annual meeting of the American...
- Idenix licenses valopicitabine to Novartis in $70M deal.(Idenix Pharmaceuticals...
- Newspaper article from: Pharma Marketletter April 3, 2006 700+ words
Idenix Pharmaceuticals, a USA-based biopharmaceutical company focused on infectious diseases, says that Novartis has exercised its option to license valopicitabine (NM283), an oral antiviral, and Idenix' lead compound...
- Idenix lowers NM283 dosage after AE reports.(Idenix Pharmaceuticals...
- Newspaper article from: Pharma Marketletter April 3, 2006 700+ words
Idenix Pharmaceuticals, a US biopharmaceutical company focused on viral and other infectious diseases, has modified its ongoing Phase IIb hepatitis C trials of its drug candidate valopicitabine (NM283) due to side effects. Dosing...
- Ciphergen Biosystems Inc., Idenix Pharmaceuticals Inc. and ExonHit Herapeutics...
- Press release article from: PR Newswire June 24, 2003 700+ words
...Executive Officer of Idenix Pharmaceuticals Inc.; and Dr...Process Division. Idenix Pharmaceuticals Inc., a biopharmaceutical...of viral and infectious diseases, was recognized...founding in 1998, Idenix Pharmaceuticals has developed...
- The Bellwether Report takes a look into Idenix Pharmaceuticals, Inc.
- Press release article from: M2 Presswire January 9, 2006 700+ words
...has a major stake in Idenix Pharmaceuticals. Idenix Pharmaceuticals, Inc., a biopharmaceutical...human viral and other infectious diseases. It primarily focuses...unbiased report on Idenix Pharmaceuticals, Inc (NASDAQ:IDIX...
- Idenix Pharmaceuticals, Inc. - Financial and Strategic Analysis Review.
- Press release article from: M2 Presswire May 6, 2009 700+ words
...new report: Idenix Pharmaceuticals, Inc. - Financial...Analysis Review Idenix Pharmaceuticals, Inc. - Financial...Review Summary Idenix Pharmaceuticals, Inc. is a...viral and other infectious diseases. The company...
- Idenix: valopicitabine Ph IIb enrollment ends.(Idenix Pharmaceuticals...
- Newspaper article from: Pharma Marketletter June 13, 2005 700+ words
Idenix Pharmaceuticals, which focuses on the generation of drugs for human viral and other infectious diseases, has completed enrollment in its Phase IIb clinical trial of valopicitabine (NM283) with more than 170 treatment refractory...